To view this email as a web page, click here.

TOP STORIES
 
Controversy surrounds Exondys 51 approval: What to know
New medicine for Duchenne muscular dystrophy raises questions. Here's whose covering it and why.
Read more
 
Non-adherence has big impact on Medicaid beneficiaries with HIV
New data presented at the International AIDS Society Conference examines the medical and financial burden of missing pills.
Read more
 
5 ways to improve patient medication adherence
Here are 5 ways healthcare organizations of all types, including managed care organizations, can improve patient adherence to prescribed medication therapies.
Read more
 
SURVEY
 
State of the Industry Survey 2017
Take three minutes to answer our State of the Industry Survey. As a thank-you to survey-takers, when the survey closes, we will hold a drawing to give away not one, but two $200 Visa gift cards.
Take survey
 
ADVERTISEMENT
Opportunities Found: Identifying Revenue Leaks in Ambulatory Care Practices
Revenue leakage – lost opportunities to collect money earned – has been a topic of conversation in healthcare for years. Granted, revenue leakage is a moving target, thanks to healthcare reform, constantly changing payer rules and frequent technology advancements.
There are no easy answers, but there is tremendous upside to finally finding and fixing current revenue leakage root causes and preventing new sources.
Download this white paper to learn more!
 
DIGITAL EDITION
Check out our latest issue featuring:
 • Make the most of predictive analytics
 • Evolving hepatitis C pipeline offers hope to patients
 • Clinical pharmacists gain prominence as the industry changes
Read more
 
ADVERTISEMENT
All Healthcare is not Local: The Human Cost of Disparate Health Data
Can you access patient data from outside systems within your existing EHR workflow? Now you can. Read how a truly national record locator service improves patient care coordination and positively impacts care quality.
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.